JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 27, 2004; DOI: 10.1124/jpet.104.071381


0022-3565/04/3113-948-953$20.00
JPET 311:948-953, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.071381v1
311/3/948    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watabe, M.
Right arrow Articles by Nakaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watabe, M.
Right arrow Articles by Nakaki, T.

CELLULAR AND MOLECULAR

Rotenone Induces Apoptosis via Activation of Bad in Human Dopaminergic SH-SY5Y Cells

Masahiko Watabe, and Toshio Nakaki

Department of Pharmacology, Teikyo University School of Medicine, Tokyo, Japan

Chronic complex I inhibition caused by rotenone induces features of Parkinson's disease in rats, including selective nigrostriatal dopaminergic degeneration and Lewy bodies with {alpha}-synuclein-positive inclusions. To determine the mechanisms underlying rotenone-induced neuronal death, we used an in vitro model of human dopaminergic SH-SY5Y cells. In rotenone-induced cell death, rotenone induced Bad dephosphorylation without changing the amount of Bad proteins. Rotenone also increased the amount of {alpha}-synuclein in cells showing morphological changes in response to rotenone. Because Bad and {alpha}-synuclein are known to bind to 14-3-3 proteins, we examined the effects of rotenone on these complexes. Whereas a decreased Bad amount bound to 14-3-3 proteins, rotenone increased {alpha}-synuclein binding to these proteins. Beccause dephosphorylation by calcineurin activates Bad, we examined the possible involvement of Bad activation in rotenone-induced apoptosis by using the calcineurin inhibitor tacrolimus (FK506). Tacrolimus suppressed two rotenone-induced actions: Bad dephosphorylation and apoptosis. Furthermore, the inhibition of caspase-9, which functions downstream from Bad, completely suppressed rotenone-induced apoptosis. Our findings demonstrate that Bad activation plays a role in rotenone-induced apoptosis of SH-SY5Y cells.


Received May 26, 2004; accepted July 27, 2004.

Address correspondence to: Dr. Toshio Nakaki, Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi Ward, Tokyo 173-8605, Japan. E-mail: nakaki{at}med.teikyo-u.ac.jp




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Watabe and T. Nakaki
Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y Cells
Mol. Pharmacol., October 1, 2008; 74(4): 933 - 940.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Watabe and T. Nakaki
Mitochondrial Complex I Inhibitor Rotenone-Elicited Dopamine Redistribution from Vesicles to Cytosol in Human Dopaminergic SH-SY5Y Cells
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 499 - 507.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Watabe, K. Aoyama, and T. Nakaki
Regulation of Glutathione Synthesis via Interaction between Glutamate Transport-Associated Protein 3-18 (GTRAP3-18) and Excitatory Amino Acid Carrier-1 (EAAC1) at Plasma Membrane
Mol. Pharmacol., November 1, 2007; 72(5): 1103 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. C. Samms, R. P. Perera, D. S. Wimalasena, and K. Wimalasena
Perturbation of Dopamine Metabolism by 3-Amino-2-(4'-halophenyl)propenes Leads to Increased Oxidative Stress and Apoptotic SH-SY5Y Cell Death
Mol. Pharmacol., September 1, 2007; 72(3): 744 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S.-L. Hsuan, H. M. Klintworth, and Z. Xia
Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways.
J. Neurosci., April 26, 2006; 26(17): 4481 - 4491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Potokar, M. Kreft, H. H. Chowdhury, N. Vardjan, and R. Zorec
Subcellular localization of Apaf-1 in apoptotic rat pituitary cells
Am J Physiol Cell Physiol, March 1, 2006; 290(3): C672 - C677.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Taille, J. El-Benna, S. Lanone, J. Boczkowski, and R. Motterlini
Mitochondrial Respiratory Chain and NAD(P)H Oxidase Are Targets for the Antiproliferative Effect of Carbon Monoxide in Human Airway Smooth Muscle
J. Biol. Chem., July 8, 2005; 280(27): 25350 - 25360.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.